Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Immune thrombocytopenia (ITP), previously called immune thrombocytopenic purpura or idiopathic thrombocytopenic purpura, is an autoimmune disorder that occurs when the body attacks its own platelets and destroys them too quickly. Platelets are a part
of blood that helps control bleeding.
More than 80 percent of children treated for ITP recover on their own in days, weeks, or months. Recurrence of ITP is uncommon, but it can occur up to several years after the initial episode and may be associated with another viral infection.
Children and young adults ITP are treated through the Blood Disorders Center at Dana-Farber/Boston Children's,
where children and teens receive care from some of the world's most experienced hematologists with deep experience in the conditions they treat.
Find in-depth information on ITP on the Boston Children's website, including answers to:
New Patient Appointments